Mycobacterial Flashcards

1
Q

Atypical Mycobacteria - Presentation

A

Common presentation - chronic pulmonary disease resembling tuberculosis (occurring mainly in adults)
Cervical adenopathy/lymphadenitis in children (M avium-intracellulare complex,M scrofulaceum)
Mycobacterium marinumis the causative agent of swimming pool granuloma
Tenosynovitis , bursae, bone and joint infections by both rapidly and slow-growing MAC andM marinumseen in tenosynovitis of the hand
Osteomyelitis of the sternum caused byM abscessusfound in clustered and sporadic outbreaks
M fortuitumandM chelonaerapidly growing strains, occasionally seen in wound, soft tissue, pulmonary, and middle ear infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atypical Mycobacteria - Clinical

A

Most common presentation in immunocompetent pediatric host - suppurative cervical or submandibular lymphadenopathy with/without systemic symptoms
M avium-intracellulare
M scrofulaceum
Fistula may occur with coalescence of involved cervical or mandibular nodes
In children infected with HIV
Most common - recurrent and persistent fever and chronic anemia
Less frequent - chronic diarrhea and recurrent abdominal pain
Catheter-related infections most common nosocomial nontuberculous mycobacterial infections (fast-growing atypical mycobacteria, e.g.M fortuitum,cause most catheter-related infections)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Atypical Mycobacteria - Workup

A

Organisms from blood, biopsy material, bone marrow, and stools grow on routine bacterial media,
Better growth on selective mycobacterial media
Nucleic acid hybridization probes using target sequences or ribosomal RNA for rapid identification of clinical isolates
Species can be identified using high-performance liquid chromatography or biochemical tests
Polymerase chain reaction (PCR)-restriction analysis of clinical isolates have been used for the identification ofM kansasii
DisseminatedM aviumcomplex (MAC) disease is most commonly diagnosed using culture of blood and bone marrow or other normally sterile tissues or body fluids
Immunocompetent patients, CXR mimics reactivation tuberculosis
Second presentation includes the presence of patchy nodular infiltrates, without cavities in a nodular distribution
CT of lung detects bronchiectasis
CT of abdomen shows multiple enlarged retroperitoneal and mesenteric lymph nodes
Fine-needle percutaneous aspiration to confirm the diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Surgical Treatment- Atypical Mycobacteria

A

Surgical excision of infected nodes is recommended for immunocompetent children with suppurative adenitis secondary toM aviumcomplex (MAC) andM scrofulaceum
I&D of fluctuant abcesses often leads to a draining sinus lasting months or years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications- Atypical Mycobacteria

A

Treatment disseminated MAC in HIV includes at least 2 antimicrobials, one being clarithromycin or azithromycin
Ethambutol preferred as 2nd drug
3rd or 4th antibiotic possible: clofazimine, rifabutin, ciprofloxacin, or amikacin
Rx for disseminated MAC disease may need to be continued for life unless sustained immune recovery with potent antiretroviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tuberculosis Overview

A

Mycobacterium tuberculosis (slow-growing, obligate aerobe, facultative, intracellular parasite – ‘red boxcars’)
Incidence of TB was declining since the early 20th century, primarily infection-control practices (quarantine)
Mid-1980s resurgence in ethnic minorities and HIV infected individuals (20-40 fold increased risk of TB)
MDR-TB is defined as resistance to the 2 most effective first-line drugs: isoniazid & rifampin
Extensively drug-resistant TB (XDR-TB), is resistant to isoniazid, rifampin, and second-line drugs used to treat MDR-TB (mortality rates similar to preantibiotic era)
TB is often not appropriately considered or patient isolated in OP or ED settings
Infectivity is high, e.g. a case of active TB in a young child indicates disease in 1 or more adults with close contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tuberculosis Pathophysiology

A

M tuberculosisusually contracted infected aerosol exposure through the lungs or mucous membranes
Immunocompetent individuals
Only 5 % show clinical disease
Rest (95%) latent/dormant infection
Decreased immune response allows M tuberculosis reactivation
Disease results from direct bacterial effects & inappropriate host immune responses to tubercular antigens
Molecular typing in US shows > 1/3 of new patient occurrences of TB result from person-to-person transmission; remainder 2/3s from reactivation of latent infection
M tuberculosissurvives and proliferates within mononuclear phagocytes that ingest the bacterium, allows M tuberculosisto invade local lymph nodes and spread to extrapulmonary sites via hematogenous routes (bone marrow, liver, spleen, kidneys, bones & brain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presentation of Tuberculosis

A

85% of patients with TB present with pulmonary complaints
Most common sites of extrapulmonary disease are mediastinal, retroperitoneal, and cervical (scrofula) lymph nodes; vertebral bodies, adrenals, meninges, and the GI tract
Infected end organs typically have high, regional oxygen tension (as in the kidneys, bones, meninges, eyes, and choroids, and in the apices of the lungs)
Principal cause of tissue destruction fromM tuberculosis- organism’s ability to incite intense host immune reactions to antigenic cell wall proteins
TB lesion is epithelioid granuloma with central caseation necrosis (primary lesion commonly within alveolar macrophages in subpleural regions of the lung; bacilli proliferate locally and spread through the lymphatics to a hilar node, forming the Ghon complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Early Tubercles

A

spherical, 0.5- to 3-mm nodules; 3 or 4 cellular zones
central caseation necrosis
inner cellular zone of epithelioid macrophages and Langhans giant cells admixed with lymphocytes
outer cellular zone of lymphocytes, plasma cells, and immature macrophages
rim of fibrosis (in healing lesions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tuberculosis Epidemiology

A

50.4% of TB cases reported from 4 states: California, Florida, New York, and Texas
2011, more than 60% of cases of TB reportedly occurred among foreign-born persons, 54% cases in 2011 identified in persons from 5 countries: Mexico (21.3%), the Philippines (11.5%), Vietnam (8.2%), India (7.6%), and China (5.6%)
Estimated 10-15 million people in the United States have latent TB infection
Globally, > 1/3 of the population is infected with tubercle bacillus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors that increase likelihood PT has TB

A

HIV infection
History of a positive purified protein derivative (PPD) test result
History of prior TB treatment
TB exposure
Travel to or emigration from a TB endemic area
Homelessness, shelter-dwelling, incarceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of active TB

A
Cough
Weight loss/anorexia
Fever
Night sweats
Hemoptysis
Chest pain
Extrapulmonary involvement in 20% of all TB cases
60% of extrapulmonary cases have no pulmonary symptoms; negative CXR or sputum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Scrofula

A

Nodular lesion with caseous exudate on chest. Mycobacterium tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Presentation of Pulmonary TB

A

Productive cough, fever, and weight loss; occasionally hemoptysis or chest pain, anorexia, fatigue, and night sweats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tuberculosis Meningitis Presentation

A

Intermittent or persistent headache for 2-3 weeks
Subtle mental status changes may progress to coma over a period of days to weeks
Fever minimal or absent
Thick grey exudate encasing CNs and blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Skeletal TB Presentation

A

Spine is most common site (Pott disease) with back pain or stiffness; lower-extremity paralysis in up to 50% with undiagnosed Pott disease
Tuberculous arthritis involves only 1 joint (hip; knee; ankle; elbow; wrist; shoulder)
Radiographic changes may not be present for weeks or months

17
Q

Genitourinary TB Presentation

A

Symptoms include flank pain, dysuria, and frequency
In men, epididymitisor a scrotal mass
In women, may mimicpelvic inflammatory disease (cause of infertility 10% worldwide; 1% industrial nations)

18
Q

Gastrointestinal TB Presentation

A

Nonhealing ulcers of the mouth or anus
Difficulty swallowing (with esophageal disease)
Abdominal pain mimickingpeptic ulcer disease(with stomach or duodenal infection)
Malabsorption (with infection of the small intestine)
Pain, diarrhea, or hematochezia (with infection of the colon)

19
Q

Lab Workup of TB

A
Sputum for acid fast smear and culture
Complete blood count (CBC)
Chemistries, including alanine aminotransferase (ALT) or aspartate aminotransferase (AST)
Alkaline phosphatase
Total bilirubin
Uric acid
Creatinine
HIV serology in all patients with tuberculosis (TB) and unknown HIV status
HCG to screen for pregnancy
HIV screening
20
Q

TB Workup

A

Chest radiography findings suggest TB and sputum smear is positive for acid-fast bacilli, initiate treatment for TB
~35% of culture-positive specimens have a negative smear
Patients without spontaneous sputum production, attempt sputum induction with hypertonic saline
Early-morning gastric aspirate to get a good specimen, especially in children
Routine culture requires more than 3-4 weeks to grow because of the 22-hour doubling time ofM tuberculosis
Radiometric or fluorescent indicator broth culture have reduced mycobacterial recovery time
Deoxyribonucleic acid (DNA) probes used to detect small numbers of mycobacterial DNA sequences
Lumbar puncture indicated if symptoms consistent with meningitis, CT /MRI reveal tuberculomas
Spine radiographs/CT/MRI if vertebral involvement (Pott disease)
Tuberculin sensitivity develops 2-10 weeks after infection and usually is lifelong

21
Q

Purified Protein Derivative

A

PPD test - intradermal injection of 5 units of purified protein derivative (26-, 27-, or 30-gauge needle)
Delayed-type hypersensitivity tests should be read between 48 and 72 hours after administration
A negative response in immunologically intact individuals measures less than 5 mm
Population-based criteria for PPD positivity are as follows:
For patients who are HIV positive, have abnormal chest radiographic findings, have significant immunosuppression, or have had recent contact with persons with active TB, the cutoff is 5 mm or more induration
For patients who are intravenous drug users, residents of nursing homes, prisoners, impoverished persons, or members of minority groups, the cutoff is 10 mm or more induration
For patients who are young and in good health, the cutoff is 15 mm or more induration
Reactions in patients who have received the bacilli Calmette-Guérin (BCG) vaccine should be interpreted the same as above, regardless of BCG history, according to CDC guidelines

22
Q

IGRA versus PPD

A

Interferon-gamma release assay (IGRA) with antigens specific forM tuberculosiscan also be used to screen for latent TB infection
Sensitivity and specificity of IGRA are comparable to those of tuberculin skin testing
2nd clinic visit is unnecessary for reading
Neither tuberculin skin testing nor IGRA testing is sufficiently sensitive to rule out TB infection
~ 20% of patients with active TB (particularly those with advanced disease) may have normal PPD test results

23
Q

Advantage of IGRA

A

One patient visit
Ex vivo tests
No booster effect
Independent of BCG vaccination

24
Q

Disadvantage of IGRA

A

High cost
More laboratory resources required
Complicated process of lymphocyte separation
Lack of prospective studies

25
Q

Treatment of tuberculosis has 3 basic therapeutic principles

A

Any regimen must use multiple drugs to whichM tuberculosisis susceptible
Therapy must be taken regularly
Therapy must continue for a period sufficient to resolve the illness

26
Q

New Cases of TB Treated with

A

4 drugs: isoniazid, rifampin, pyrazinamide, and either ethambutol or streptomycin for 2 months; they are then treated with a continuation phase of 4 months with isoniazid and rifampin

27
Q

Retreatment cases of TB

A

initially receive at least 5 drugs, including isoniazid, rifampin, and at least 2 new drugs to which the patient has not been exposed

28
Q

Treatment of Multidrug-Resistant TB

A

Treatment must be started empirically prior to culture results; once results are known modification of therapy is necessary according to susceptibilities (costs are many times higher for the treatment of MDR-TB)
Initiate treatment with at least 3-5 previously unused drugs in which there is in vitro susceptibility
Never add a single new drug to a failing regimen
Administer at least 3 (preferably 4-5) of following according to drug susceptibilities:

29
Q

Administer at least 3 (preferably 4-5) of following according to drug susceptibilities for Multi resistant TB

A

Aminoglycosides (ie, streptomycin, amikacin, capreomycin, kanamycin)
Fluoroquinolone (ie, levofloxacin, ciprofloxacin, ofloxacin)
Thioamides (ie. ethionamide; prothionamide; pyrazinamide)
Ethambutol
Cycloserine
Terizodone
Para-aminosalicylic acid

30
Q

TB Posttreatment

A

Chest radiograph taken after therapy was administered to a patient with tuberculosis

31
Q

Tuberculosis – Rx for Latent TB

A

DO NOT MEMORIZE JUST HAVE AN IDEA
Positive tuberculin skin testing or a positive IGRA result should receive a course of therapy once active infection and disease are ruled out (CDC guidelines for latent tuberculosis:
Isoniazid 300 mg PO daily for 9 months
Isoniazid 900 mg PO twice weekly for 9 months (administered as DOT)
Isoniazid 300 mg PO daily for 6 months
Should not be used in patients with fibrotic lesions on chest radiography, patients with HIV, or children
Isoniazid 900 mg PO twice weekly for 6 months
Administered as DOT
Should not be used in patients with fibrotic lesions on chest radiography, patients with HIV, or children
Rifampin 600 mg PO daily for 4 months

Isoniazid 900 mg PO plus rifapentine 900 mg PO once weekly for 3 months
Consider use of 3-month regimen among populations that are unlikely to complete 9 months of daily therapy (e.g., in correctional settings, clinics for recent immigrants, homeless shelters)
Use for children aged 2-11 years and patients with underlying conditions associated with TB should be considered on a case-by-case basis
Not recommended for children < 2 years, pregnant women or women planning to become pregnant, HIV-infected persons taking antiretrovirals, and patients whose TB infection is presumed to be the result of exposure to a person with TB disease that is resistant to 1 of the 2 drugs